Histone acetyltransferases regulate HIV-1 enhancer activity in vitro

Genes and Development

Volumn 11, Issue 24, 1997, Pages 3327-3340

  Sheridan, Philip L ^a,c   Mayall, Timothy P ^a   Verdin, Eric ^b,d   Jones, Katherine A ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b PICOWER INST FOR MEDICAL RESEARCH   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chromatin remodeling; Histone acetylation; HIV 1 enhancer

Indexed keywords

DETERGENT; ENZYME INHIBITOR; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE H4; TRANSCRIPTION FACTOR; TRICHOSTATIN A; VIRUS RNA;

ARTICLE; CHROMATIN; DNA TEMPLATE; ENHANCER REGION; GENE EXPRESSION REGULATION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0031455415     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.24.3327     Document Type: Article

References (66)

1. Ayer, D.E., Q.A. Lawrence, and R.N. Eisenman. 1995. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 89:341-347.
2. Bannister, A.J. and T. Kouzarides. 1996. The CBP co-activator is a histone acetyltransferase. Nature 384: 641-643.
3. Brownell, J.E., J. Zhou, T. Ranalli, R. Kobayashi, D.G. Edmonson, S.Y. Roth, and C.D. Allis. 1996. Tetrahymena histone acetyltransferase A: A homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell 84: 843-851.
4. Bulger, M. and J.T. Kadonaga. 1994. Biochemical reconstitution of chromatin with physiological nucleosome spacing. Methods Mol. Genet. 5: 241-262.
5. Candau, R., J.X. Zhou, C.D. Allis, and S.L. Berger. 1997. Histone acetyltransferase activity and interaction with ADA2 are critical for GCN5 function in vivo. EMBO J. 16: 555-565.
6. Carlsson, P., M.L. Waterman, and K.A. Jones. 1993. The hLEF/ TCF-Iα HMG protein contains a context-dependent activation domain that induces the TCRα enhancer in T cells. Genes & Dev. 7: 2418-2430.
7. Chen, H., R. Lin, R. Schlitz, D. Chakravarti, A. Nash, L. Nagy, M. Privalsky, Y. Nakatani, and R.M. Evans. 1997. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90: 569-580.
8. El Kharroubi, A. and E. Verdin. 1994. Protein-DNA interactions within DNase I-hypersensitive sites located downstream of the HIV-1 promoter. J. Biol. Chem. 269: 19916-19924.
9. El Kharroubi, A. and M.A. Martin. 1996. cis-acting sequences located downstream of the human immunodeficiency virus type 1 promoter affect its chromatin structure and transcriptional activity. Mol. Cell. Biol. 16: 2958-2966.
10. Fascher, K.-D., J. Schmitz, and W. Hörz. 1993. Structural and functional requirements for the chromatin transition at the PHO5 promoter in Saccharomyces cerevisiae upon PHO5 activation. J. Mol. Biol. 231: 658-667.
11. Gaudreau, L., A. Schmid, D. Blaschke, M. Ptashne, and W. Hörz. 1997. RNA polymerase II holoenzyme recruitment is sufficient to remodel chromatin at the yeast PHO5 promoter. Cell 89: 55-62.
12. Gerritsen, M.E., A.J. Williams, A.S. Neish, S. Moore, Y. Shi, and T. Collins. 1997. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc. Natl. Acad. Sci. 94: 2927-2932.
13. Giese, K. and R. Grosschedl. 1993. LEF-1 contains an activation domain that stimulates transcription only in a specific context of factor-binding sites. EMBO J. 12: 4667-4676.
14. Giese, K., J. Cox, and R. Grosschedl. 1992. The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 69: 185-196.
15. Grunstein, M. 1997. Histone acetylation in chromatin structure and transcription. Nature 389: 349-352.
16. Gu, W. and R.G. Roeder. 1997. Activation of p53 sequence-specific DNA binding by acetylation of the p53 c-terminal domain. Cell 90: 595-606.
17. Hawley, D.K. and R.G. Roeder. 1985. Separation and partial characterization of three functional steps in transcription initiation by human RNA polymerase II. J. Biol. Chem. 260: 8163-8172.
18. _. 1987. Functional steps in initiation and reinitiation from the major late promoter in a HeLa nuclear extract. J. Biol. Chem. 262: 3452-3461.
19. Heinzel, T., R. Lavinsky, T.-M. Mullen, M. Soderstrom, C. Laherty, W.-M. Torchia, C. Glass, and M.G. Rosenfeld. 1997. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387: 43-48.
20. Ito, T., M. Bulger, M. Pazin, R. Kobayashi, and J.T. Kadonaga. 1997. ACF, an ISWI-containing and ATP-utilizing chromatin assembly and remodeling factor. Cell 90: 145-155.
21. Jones, K.A., P.A. Luciw, and N. Duchange. 1988. Structural arrangements of transcription control domains within the 5′-untranslated leader regions of the HIV-1 and HIV-2 promoters. Genes & Dev. 2: 1101-1114.
22. Kamakaka, R.T., M. Bulger, and J.T. Kadonaga. 1993. Potentiation of RNA polymerase II transcription by Gal4-VP16 during but not after DNA replication and chromatin assembly. Genes & Dev. 7: 1779-1795.
23. Karin, M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol Chem. 270: 16483-16486.
24. Kato, H., M. Horikoshi, and R.G. Roeder. 1991. Repression of HIV-1 transcription by a cellular protein. Science 251: 1476-1479.
25. Laherty, C.D., W.-M. Yan, J.-M. Sun, J.R. Davie, E. Seto, and R.N. Eisenman. 1997. Histone deacetylases associated with the mSin3 corepressor mediate Mad transcriptional repression. Cell 89: 349-356.
26. Lim, L.C., S.L. Swendeman, and M. Sheffery. 1992. Molecular cloning of the α-globin transcription factor CP2. Mol. Cell. Biol. 12: 828-835.
27. Lin, R., J.W. Leone, R.G. Cook, and C.D. Allis. 1989. Antibodies specific to acetylated histones document the existence of deposition-and transcription-related histone acetylation in Tetrahymena. J. Cell Biol. 108: 1577-1588.
28. Lorch, Y., J.W. LaPointe, and R.D. Kornberg. 1992. Initiation on chromatin templates in a yeast RNA polymerase II transcription system. Genes & Dev. 6: 2282-2287.
29. Maruyama, M., T. Fujita, and T. Taniguchi. 1989. Sequence of a cDNA coding for human IRF-1. Nucleic Acids Res. 17: 3292.
30. Mayall, T.P., P.L. Sheridan, M.R. Montminy, and K.A. Jones. 1997. Distinct roles for P-CREB and LEF-1 in TCRα enhancer assembly and activation on chromatin templates in vitro. Genes & Dev. 11: 887-899.
31. II250 subunit of TFIID has histone acetyltransferase activity. Cell 87: 1261-1270.
32. Mymryk, J. and T. Archer. 1995. Dissection of progesterone receptor-mediated chromatin remodeling and transcriptional activation in vivo. Genes & Dev. 9: 1366-1376.
33. Nagy, L., H.-Y. Kao, D. Chakravarti, R.J. Lin, C.A. Hassig, D.E. Ayer, S.L. Schreiber, and R.M. Evans. 1997. Nuclear receptor repression mediated by a complex containing SMRT, mSinSA and histone deacetylase. Cell 89: 373-380.
34. Ogryzko, V.V., R.L. Schiltz, V. Russanova, B.H. Howard, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953-959.
35. Paranjape, S.M., R.T. Kamakaka, and J.T. Kadonaga. 1994. Role of chromatin structure in the regulation of transcription by RNA polymerase II. Annu. Rev. Biochem. 63: 265-297.
36. Parker, S.F., L.K. Felzien, N.D. Perkins, M.J. Imperiale, and G.J. Nabel. 1997. Distinct domains of adenovirus E1A interact with specific cellular factors to differentially modulate human immunodeficiency virus transcription. J. Virol. 71: 2004-2012.
37. Pazin, M.J. and J.T. Kadonaga. 1997. What's up and down with histone deacetylation and transcription? Cell 89: 325-328.
38. Pazin, M.J., R.T. Kamakaka, and J.T. Kadonaga. 1994. ATP-dependent nucleosome reconfiguration and transcriptional activation from preassembled chromatin templates. Science 266: 2007-2011.
39. Pazin, M.J., P.L. Sheridan, K. Cannon, Z. Cao, J.G. Keck, J.T. Kadonaga, and K.A. Jones. 1996. NF-κB medicated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro. Genes & Dev. 10: 37-49.
40. Pazin, M., P. Bhargava, E. Geiduschek, and J. Kadonaga. 1997. Nucleosome mobility and the maintenance of nucleosome positioning. Science 276: 809-812.
41. Peterson, C. and J. Tamkun. 1995. The SWI-SNF complex: A chromatin remodeling machine? Trends Biochem. Sci. 20: 143-146.
42. Ron, D. and H. Dressler. 1992. pGSTag - A versatile bacterial expression plasmid for enzymatic labeling of recombinant proteins. Biotechnology 13: 866-869.
43. Rothe, S.Y. and C.D. Allis. 1996. Histone acetylation and chromatin assembly: A single escort, multiple dances. Cell 87: 5-8.
44. Sheridan, P.L., C.T. Sheline, K. Cannon, M.L. Voz, M.J. Pazin, J.T. Kadonaga, and K.A. Jones. 1995. Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro. Genes & Dev. 9: 2090-2104.
45. Steger, D.J. and J.L. Workman. 1997. Stable co-occupancy of transcription factors and histones at the HIV-1 enhancer. EMBO J. 16: 2463-2472.
46. Sternglanz, R. 1996. Histone acetylation: A gateway to transcriptional activation. Trends Biochem. Sci. 21: 357-358.
47. Straka, C. and W. Hörz. 1991. A functional role for nucleosomes in the repression of a yeast promoter. EMBO J. 10: 361-368.
48. Svaren, J. and W. Hörz. 1997. Transcription factors vs nucleosomes: Regulation of the PHO5 promoter in yeast. Trends Biochem. Sci. 22: 93-97.
49. Svaren, J., J. Schmitz, and W. Horz. 1994. The transactivation domain of Pho4 is required for nucleosome disruption at the PHO5 promoter. EMBO J. 13: 4856-4862.
50. Timmerman, L.A., N.A. Clipstone, S.N. Ho, J.P. Northrop, and G.R. Crabtree. 1996. Rapid shuttling of NF-AT in discrimination of Ca2+ signals and immunosuppression. Nature 383: 837-840.
51. Tsukiyama, T., P. Becker, and C. Wu. 1995. ISWI, a member of the SWI2/SNF2 ATPase family, encodes the 140kDa subunit of the nucleosome remodeling factor. Cell 83: 1021-1026.
52. Van Lint, C., S. Emiliani, M. Ott, and E. Verdin. 1996a. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J. 15: 1112-1120.
53. Van Lint, C., S. Emiliani, and E. Verdin. 1996b. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr. 5: 245-253.
54. Van Lint, C., C.A. Amelia, S. Emiliani, M. John, T. Jie, and E. Verdin. 1997. Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity. J. Virol. 71: 6113-6127.
55. Verdin, E. 1991. DNase I-hypersensitive sites are associated with both long terminal repeats and with the intragenic enhancer of intergrated human immunodeficiency virus type 1. J. Virol. 65: 6790-6799.
56. Verdin, E., P. Para Jr., and C. Van Lint. 1993. Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J. 12: 3249-3259.
57. Volker, J.L., L.E. Rameh, Q. Zhu, J. DeCaprio, and U. Hansen. 1997. Mitogenic stimulation of resting T cells causes rapid phosphorylation of the transcription factor LSF and increased DNA-binding activity. Genes & Dev. 11: 1435-1446.
58. Wade, D.A., D. Pruss, and A.P. Wolffe. 1997. Histone acetylation: Chromatin in action. Trends Biochem. Sci. 22: 128-132.
59. Walters, M., W. Magis, S. Fiering, J. Eidemiller, D. Scalzo, M. Groudine, and D. Martin. 1996. Transcriptional enhancers act in cis to suppress position-effect variegation. Genes & Dev. 10: 185-195.
60. Wang, L., C. Mizzen, C. Ying, R. Candau, N. Barlev, J. Brownell, C.D. Allis, and S.L. Berger. 1997. Histone acetyltransferase activity is conserved between yeast and human GCN5 and is required for complementation of growth and transcriptional activation. Mol. Cell. Biol. 17: 519-527.
61. Wechser, M.A., M.P. Kladde, J.A. Alfieri, and C.L. Peterson. 1997. Effects of Sin-versions of histone H4 on yeast chromatin structure and function. EMBO J. 16: 2086-2095.
62. Widlak, P., R.B. Gaynor, and W.T. Garrard. 1997. In vitro chromatin assembly of the HIV-1 promoter. ATP-dependent polar positioning of nucleosomes by Sp1 and NFkappaB. J. Biol. Chem. 272: 17654-17661.
63. Wolffe, A.P. and D. Pruss. 1996. Targeting chromatin disruption: Transcription regulators that acetylate histones. Cell 84: 817-819.
64. Yang, X.-J., V.V. Ogryzko, J. Nishikawa, B.H. Howard, and Y. Nakatani. 1996. A p300/CBP-associated factor that competes with the adenoviral oncoprotein EIA. Nature 382: 319-324.
65. Yoon, J.B., G. Li, and R.G. Roeder. 1994. Characterization of a family of related cellular transcription factors which can modulate human immunodeficiency virus type 1 transription in vitro. Mol. Cell. Biol. 14: 1776-1785.
66. Yoshida, M., S. Horinouoshi, and T. Beppu. 1995. Trichostatin A and trapoxin: Novel chemical probes for the role of histone acetylation in chromatin structure and function. BioEssays 17: 423-430.